{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T21:09:14Z","timestamp":1779224954006,"version":"3.51.4"},"reference-count":30,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_med-2025-1275_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To analyze differences in coagulation function and plasma inflammatory factors between type 2 diabetes mellitus (T2DM) patients with and without ischemic stroke (IS), and explore related mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_med-2025-1275_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>50 patients with T2DM complicated with IS (experimental group, EG) and 50 patients with simple T2DM (control group, CG) were retrospectively included, while 30 healthy volunteers served as the blank group (BG). The expression levels of plasma interleukin-6 (IL-6), tumor necrosis factor-\u03b1 (TNF-\u03b1), and nuclear factor-\u03baB (NF-\u03baB) in the EG were significantly elevated as against the CG and the BG (p&lt;0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_med-2025-1275_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      As against the CG and the BG, activated partial thromboplastin time (APTT) and prothrombin time (PT) levels were significantly reduced, while the plasma fibrinogen (FIB) and D-Dimer (DD) levels were significantly elevated in the EG; The incidence of postoperative complications in the EG (13.46\u202f%) was significantly reduced as against the CG (21.15\u202f%) (p&lt;0.05). IL-6 was notably negatively correlated with APTT (p\n                      <jats:italic>=<\/jats:italic>\n                      0.002,\n                      <jats:italic>r=<\/jats:italic>\n                      \u22120.432); it was extremely significantly negatively correlated with PT (p\n                      <jats:italic>=<\/jats:italic>\n                      0.000,\n                      <jats:italic>r=<\/jats:italic>\n                      \u22120.536); it was notably positively correlated with plasma FIB content (p\n                      <jats:italic>=<\/jats:italic>\n                      0.001,\n                      <jats:italic>r=<\/jats:italic>\n                      0.445).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_med-2025-1275_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The coagulation function and peripheral blood inflammatory markers in patients with T2DM complicated by IS were significantly different compared to those in patients with T2DM alone and healthy volunteers. The correlation between inflammatory markers and coagulation indicators (\n                      <jats:italic>e.g.,<\/jats:italic>\n                      the negative correlation between IL-6 and APTT\/PT) identified in this study holds important clinical significance. It provides new insights for thrombosis risk stratification and personalized antithrombotic treatment in T2DM patients. Monitoring the levels of inflammatory markers may optimize thrombosis prevention strategies and enhance the precision of clinical diagnosis and treatment.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/med-2025-1275","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:20:42Z","timestamp":1773940842000},"source":"Crossref","is-referenced-by-count":0,"title":["Correlation analysis of coagulation factor level and chronic low-grade inflammation in patients with type 2 diabetes mellitus complicated with ischemic stroke"],"prefix":"10.1515","volume":"21","author":[{"given":"Li","family":"Weng","sequence":"first","affiliation":[{"name":"Department of Endocrinology , People\u2019s Hospital of Qijiang District , Chongqing , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology , People\u2019s Hospital of Qijiang District , Chongqing , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9351-2437","authenticated-orcid":false,"given":"Dejuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology , People\u2019s Hospital of Qijiang District , Chongqing , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"2026051921043349496_j_med-2025-1275_ref_001","doi-asserted-by":"crossref","unstructured":"Lim, HY, Lui, B, Tacey, M, Kwok, A, Varadarajan, S, Donnan, G, et al.. Global coagulation assays in patients with diabetes mellitus. Res Pract Thromb Haemost 2021;5:e12611. https:\/\/doi.org\/10.1002\/rth2.12611.","DOI":"10.1002\/rth2.12611"},{"key":"2026051921043349496_j_med-2025-1275_ref_002","doi-asserted-by":"crossref","unstructured":"Arnold, SE, Arvanitakis, Z, Macauley-Rambach, SL, Koenig, AM, Wang, HY, Ahima, RS, et al.. Brain insulin resistance in type 2 diabetes and alzheimer disease: concepts and conundrums. Nat Rev Neurol 2018;14:168\u201381. https:\/\/doi.org\/10.1038\/nrneurol.2017.185.","DOI":"10.1038\/nrneurol.2017.185"},{"key":"2026051921043349496_j_med-2025-1275_ref_003","doi-asserted-by":"crossref","unstructured":"Longo, S, Rizza, S, Federici, M. Microbiota-gut-brain axis: relationships among the vagus nerve, gut microbiota, obesity, and diabetes. Acta Diabetol 2023;60:1007\u201317. https:\/\/doi.org\/10.1007\/s00592-023-02088-x.","DOI":"10.1007\/s00592-023-02088-x"},{"key":"2026051921043349496_j_med-2025-1275_ref_004","doi-asserted-by":"crossref","unstructured":"Agrawal, R, Reno, CM, Sharma, S, Christensen, C, Huang, Y, Fisher, SJ. Insulin action in the brain regulates both central and peripheral functions. Am J Physiol Endocrinol Metab 2021;321:E156\u201363. https:\/\/doi.org\/10.1152\/ajpendo.00642.2020.","DOI":"10.1152\/ajpendo.00642.2020"},{"key":"2026051921043349496_j_med-2025-1275_ref_005","doi-asserted-by":"crossref","unstructured":"Liu, H, Tang, T. MAPK signaling pathway-based glioma subtypes, machine-learning risk model, and key hub proteins identification. Sci Rep 2023;13:19055. https:\/\/doi.org\/10.1038\/s41598-023-45774-0.v.","DOI":"10.1038\/s41598-023-45774-0"},{"key":"2026051921043349496_j_med-2025-1275_ref_006","doi-asserted-by":"crossref","unstructured":"Tirr\u00f2, E, Massimino, M, Romano, C, Martorana, F, Pennisi, MS, Stella, S, et al.. Prognostic and therapeutic roles of the insulin growth factor system in glioblastoma. Front Oncol 2021;10:612385. https:\/\/doi.org\/10.3389\/fonc.2020.612385.","DOI":"10.3389\/fonc.2020.612385"},{"key":"2026051921043349496_j_med-2025-1275_ref_007","doi-asserted-by":"crossref","unstructured":"Sabari, SS, Balasubramani, K, Iyer, M, Sureshbabu, HW, Venkatesan, D, Gopalakrishnan, AV, et al.. Type 2 diabetes (T2DM) and Parkinson\u2019s disease (PD): a mechanistic approach. Mol Neurobiol 2023;60:4547\u201373. https:\/\/doi.org\/10.1007\/s12035-023-03359-y.","DOI":"10.1007\/s12035-023-03359-y"},{"key":"2026051921043349496_j_med-2025-1275_ref_008","doi-asserted-by":"crossref","unstructured":"Chen, YC, Lu, BZ, Shu, YC, Sun, YT. Spatiotemporal dynamics of cerebral vascular permeability in type 2\u00a0diabetes-related cerebral microangiopathy. Front Endocrinol 2022;12:805637. https:\/\/doi.org\/10.3389\/fendo.2021.805637.","DOI":"10.3389\/fendo.2021.805637"},{"key":"2026051921043349496_j_med-2025-1275_ref_009","doi-asserted-by":"crossref","unstructured":"Li, Y, Jiang, T, Du, M, He, S, Huang, N, Cheng, B, et al.. Ketohexokinase-dependent metabolism of cerebral endogenous fructose in microglia drives diabetes-associated cognitive dysfunction. Exp Mol Med 2023;55:2417\u201332. https:\/\/doi.org\/10.1038\/s12276-023-01112-y.","DOI":"10.1038\/s12276-023-01112-y"},{"key":"2026051921043349496_j_med-2025-1275_ref_010","doi-asserted-by":"crossref","unstructured":"\u0130lik, \u0130, Arslan, H, Yoku\u015f, A, Batur, M, \u00dc\u00e7ler, R, Akdeniz, H. Cerebral perfusion in type 2 diabetes mellitus: a preliminary study with MR perfusion. Clin Neurol Neurosurg 2023;231:107816. https:\/\/doi.org\/10.1016\/j.clineuro.2023.107816.","DOI":"10.1016\/j.clineuro.2023.107816"},{"key":"2026051921043349496_j_med-2025-1275_ref_011","doi-asserted-by":"crossref","unstructured":"Xia, W, Rao, H, Spaeth, AM, Huang, R, Tian, S, Cai, R, et al.. Blood pressure is associated with cerebral blood flow alterations in patients with T2DM as revealed by perfusion functional MRI. Medicine 2015;94:e2231. https:\/\/doi.org\/10.1097\/md.0000000000002231.","DOI":"10.1097\/MD.0000000000002231"},{"key":"2026051921043349496_j_med-2025-1275_ref_012","doi-asserted-by":"crossref","unstructured":"Teng, Z, Feng, J, Liu, R, Dong, Y, Chen, H, Xu, J, et al.. Cerebral small vessel disease is associated with mild cognitive impairment in type 2 diabetes mellitus. Diabetes Metab Syndr Obes 2022;15:1985\u201394. https:\/\/doi.org\/10.2147\/DMSO.S368725.","DOI":"10.2147\/DMSO.S368725"},{"key":"2026051921043349496_j_med-2025-1275_ref_013","doi-asserted-by":"crossref","unstructured":"Chau, ACM, Cheung, EYW, Chan, KH, Chow, WS, Shea, YF, Chiu, PKC, et al.. Impaired cerebral blood flow in type 2 diabetes mellitus\u00a0\u2013\u00a0a comparative study with subjective cognitive decline, vascular dementia and Alzheimer\u2019s disease subjects. Neuroimage Clin 2020;27:102302. https:\/\/doi.org\/10.1016\/j.nicl.2020.102302.","DOI":"10.1016\/j.nicl.2020.102302"},{"key":"2026051921043349496_j_med-2025-1275_ref_014","doi-asserted-by":"crossref","unstructured":"Fang, F, Cao, R, Luo, Q, Ge, R, Lai, M, Yang, J, et al.. The silent occurrence of cerebral small vessel disease in nonelderly patients with type 2 diabetes mellitus. J\u00a0Diabetes 2021;13:735\u201343. https:\/\/doi.org\/10.1111\/1753-0407.13164.","DOI":"10.1111\/1753-0407.13164"},{"key":"2026051921043349496_j_med-2025-1275_ref_015","doi-asserted-by":"crossref","unstructured":"Huang, J, Zhang, X, Li, J, Tang, L, Jiao, X, Lv, X. Impact of glucose fluctuation on acute cerebral infarction in type 2 diabetes. Can J Neurol Sci 2014;41:486\u201392. https:\/\/doi.org\/10.1017\/s0317167100018539.","DOI":"10.1017\/S0317167100018539"},{"key":"2026051921043349496_j_med-2025-1275_ref_016","doi-asserted-by":"crossref","unstructured":"Toor, SM, Aldous, EK, Parray, A, Akhtar, N, Al-Sarraj, Y, Abdelalim, EM, et al.. Identification of distinct circulating microRNAs in acute ischemic stroke patients with type 2 diabetes mellitus. Front Cardiovasc Med 2022;9:1024790. https:\/\/doi.org\/10.3389\/fcvm.2022.1024790.","DOI":"10.3389\/fcvm.2022.1024790"},{"key":"2026051921043349496_j_med-2025-1275_ref_017","doi-asserted-by":"crossref","unstructured":"Chen, C, Zhu, J, Deng, X, Yang, Z, Lin, W, Ma, Y, et al.. Severe periodontitis is associated with the serum levels of hypersensitive C reactive protein and lipoprotein-associated phospholipase A2 in the patients of acute ischemic stroke. J\u00a0Clin Neurosci 2021;88:232\u20136. https:\/\/doi.org\/10.1016\/j.jocn.2021.04.007.","DOI":"10.1016\/j.jocn.2021.04.007"},{"key":"2026051921043349496_j_med-2025-1275_ref_018","doi-asserted-by":"crossref","unstructured":"Liu, P, Hao, J, Zhang, Y, Wang, L, Liu, C, Wang, J, et al.. Acute ischemic stroke comorbid with type 2 diabetes: long-term prognosis determinants in a 36-month prospective study for personalized medicine. OMICS 2022;26:451\u201360. https:\/\/doi.org\/10.1089\/omi.2022.0071.","DOI":"10.1089\/omi.2022.0071"},{"key":"2026051921043349496_j_med-2025-1275_ref_019","doi-asserted-by":"crossref","unstructured":"Chen, DY, Wang, SH, Mao, CT, Tsai, ML, Lin, YS, Su, FC, et al.. Sitagliptin after ischemic stroke in type 2 diabetic patients: a nationwide cohort study. Medicine 2015;94:e1128. https:\/\/doi.org\/10.1097\/md.0000000000001128.","DOI":"10.1097\/MD.0000000000001128"},{"key":"2026051921043349496_j_med-2025-1275_ref_020","doi-asserted-by":"crossref","unstructured":"Zhou, H, Huang, L, Liang, L, Chen, L, Zou, C, Li, Z, et al.. Identification of an miRNA regulatory network and candidate markers for ischemic stroke related to diabetes. Int J Gen Med 2021;14:3213\u201323. https:\/\/doi.org\/10.2147\/ijgm.s319503.","DOI":"10.2147\/IJGM.S319503"},{"key":"2026051921043349496_j_med-2025-1275_ref_021","doi-asserted-by":"crossref","unstructured":"Song, X, He, Y, Bai, J, Zhang, J. A nomogram based on nutritional status and A2DS2 score for predicting stroke-associated pneumonia in acute ischemic stroke patients with type 2 diabetes mellitus: a retrospective study. Front Nutr 2022;9:1009041. https:\/\/doi.org\/10.3389\/fnut.2022.1009041.","DOI":"10.3389\/fnut.2022.1009041"},{"key":"2026051921043349496_j_med-2025-1275_ref_022","doi-asserted-by":"crossref","unstructured":"Kwok, MK, Kawachi, I, Rehkopf, D, Schooling, CM. The role of cortisol in ischemic heart disease, ischemic stroke, type 2 diabetes, and cardiovascular disease risk factors: a bi-directional Mendelian randomization study. BMC Med 2020;18:363. https:\/\/doi.org\/10.1186\/s12916-020-01831-3.","DOI":"10.1186\/s12916-020-01831-3"},{"key":"2026051921043349496_j_med-2025-1275_ref_023","doi-asserted-by":"crossref","unstructured":"Karam, RA, Amer, MM, Zidan, HE. Long noncoding RNA NEAT1 expression and its target miR-124 in diabetic ischemic stroke patients. Genet Test Mol Biomark 2022;26:398\u2013407. https:\/\/doi.org\/10.1089\/gtmb.2021.0301.","DOI":"10.1089\/gtmb.2021.0301"},{"key":"2026051921043349496_j_med-2025-1275_ref_024","doi-asserted-by":"crossref","unstructured":"Adcock, DM, Moore, GW, Montalv\u00e3o, SL, Kershaw, G, Gosselin, RC. Activated partial thromboplastin time and prothrombin time mixing studies: current state of the art. Semin Thromb Hemost 2023;49:571\u20139. https:\/\/doi.org\/10.1055\/s-0042-1756196.","DOI":"10.1055\/s-0042-1756196"},{"key":"2026051921043349496_j_med-2025-1275_ref_025","doi-asserted-by":"crossref","unstructured":"Zhang, S, Li, Y, Zhang, J, Sun, Y, Chu, X, Gui, X, et al.. Platelet-derived TGF-\u03b21 promotes deep vein thrombosis. Thromb Haemost 2024;124:641\u20138. https:\/\/doi.org\/10.1055\/a-2235-7485.","DOI":"10.1055\/a-2235-7485"},{"key":"2026051921043349496_j_med-2025-1275_ref_026","doi-asserted-by":"crossref","unstructured":"Liu, J, Li, X, Qu, J. Risk factors for acute ischemic stroke in patients with type 2 diabetes mellitus. Medicine 2023;102:e36114. https:\/\/doi.org\/10.1097\/MD.0000000000036114.","DOI":"10.1097\/MD.0000000000036114"},{"key":"2026051921043349496_j_med-2025-1275_ref_027","doi-asserted-by":"crossref","unstructured":"G\u00f6bel, K, Eichler, S, Wiendl, H, Chavakis, T, Kleinschnitz, C, Meuth, SG. The coagulation factors fibrinogen, thrombin, and factor XII in inflammatory disorders-a systematic review. Front Immunol 2018;9:1731. https:\/\/doi.org\/10.3389\/fimmu.2018.01731.","DOI":"10.3389\/fimmu.2018.01731"},{"key":"2026051921043349496_j_med-2025-1275_ref_028","doi-asserted-by":"crossref","unstructured":"Wang, CB, Zong, M, Lu, SQ, Tian, Z. Plasma copeptin and functional outcome in patients with ischemic stroke and type 2 diabetes. J\u00a0Diabet Complicat 2016;30:1532\u20136. https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.07.030.","DOI":"10.1016\/j.jdiacomp.2016.07.030"},{"key":"2026051921043349496_j_med-2025-1275_ref_029","doi-asserted-by":"crossref","unstructured":"Attiq, A, Afzal, S, Ahmad, W, Kandeel, M. Hegemony of inflammation in atherosclerosis and coronary artery disease. Eur J Pharmacol 2024;966:176338. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176338.","DOI":"10.1016\/j.ejphar.2024.176338"},{"key":"2026051921043349496_j_med-2025-1275_ref_030","doi-asserted-by":"crossref","unstructured":"Kang, S, Kishimoto, T. Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms. Exp Mol Med 2021;53:1116\u201323. https:\/\/doi.org\/10.1038\/s12276-021-00649-0.","DOI":"10.1038\/s12276-021-00649-0"}],"container-title":["Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2025-1275\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2025-1275\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T21:04:46Z","timestamp":1779224686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2025-1275\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,20]]},"published-print":{"date-parts":[[2026,1,23]]}},"alternative-id":["10.1515\/med-2025-1275"],"URL":"https:\/\/doi.org\/10.1515\/med-2025-1275","relation":{},"ISSN":["2391-5463"],"issn-type":[{"value":"2391-5463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"20251275"}}